BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
SNCA
,
cell-cell adhesion
,
Ischemia
,
Pancreas
,
Laryngoscope
,
Rosiglitazone
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD138
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Conjunctiva
Placenta
Oral mucosa
Esophagus
Pharyngeal mucosa
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Vaccination status
Protozoan infection
Nerve injury
Pain
COVID-19
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
FluLaval
monastrol
Aclarubicin
Caerulein
Inhba protein, mouse
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
NOTCH1
Ikzf1
ATF3
ARHGAP5
PRKAR1A
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Syndecan-1: A Novel Diagnostic and Therapeutic Target in Liver Diseases.
Association of Preoperative and Postoperative Plasma Syndecan-1 and Colorectal Cancer Outcome.
High expression of SDC1 in stromal cells is associated with good prognosis in colorectal cancer.
Diagnosis of rare entity CD138 negative plasma cell multiple myeloma: the synergy between laboratory…
Soluble Endoglin and Syndecan-1 levels predicts the clinical outcome in COVID-19 patients.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Relationship Between CD138 Count of Endometrium and Reproductive Outcome
Integrin β7, BCMA, CS1, CD38 and CD138 as the Single or Compound Targets for the Fourth Genenation o…
Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma
Study of T Cells Targeting CD138/BCMA/CD19/More Antigens (CART-138/BCMA/19/More) for Chemotherapy Re…
Treatment of Chemotherapy Refractory Multiple Myeloma by CART-138
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ